Cover Image
市場調查報告書

MediPoint:運動醫學 - 美國市場的分析與預測

MediPoint: Sports Medicine - US Analysis and Market Forecasts

出版商 GlobalData 商品編碼 299427
出版日期 內容資訊 英文 175 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:運動醫學 - 美國市場的分析與預測 MediPoint: Sports Medicine - US Analysis and Market Forecasts
出版日期: 2014年03月31日 內容資訊: 英文 175 Pages
簡介

在整形外科移植市場成熟化之中,運動醫學為今後大幅成長的領域而受關注。在美國隨著運動相關損傷在青年人和老年人層都增加,運動醫學市場急速成長。

本報告提供美國的運動醫學市場(移植、內視鏡檢驗用設備)相關分析、疾病概要和市場結構、目前未滿足需求、主要的推動及阻礙市場要素、今後的市場機會、現在臨床實驗中的主要產品、美國市場趨勢(過去3年的實際成果值和今後7年的預測值)、各類型產品的詳細趨勢,再加上主要企業簡介等調查,並將結果概述為以下內容。

第1章 目錄

第2章 簡介

第3章 臨床結果

  • 保存療法
    • 患部固定和矯正器具
    • 理療
    • 肌肉刺激
  • 藥物療法
    • 營養補充劑
    • 止痛藥和NSAID(非類固醇消炎劑)
    • 皮質類固醇(皮質類固醇)
    • 關節內粘稠補充療法
  • 軟組織的修復
  • 關節鏡檢查
  • 陽極、螺絲
  • 關節重建

第4章 產業概要

  • 概要
  • 治療的趨勢:美國的情況
  • 市場進入:美國的情況
  • 糾紛與其解決(共4件)
  • 企業合併、收購(M&A)、夥伴關係、其他資本交易(共9件)
  • 經濟上的影響
    • 先進國家市場的情況
    • 新興國家市場的情況

第5章 未滿足需求

  • 長期性的臨床資料
    • 股關節移植的內視鏡手術的情況
    • 迴旋肩迴旋肌損傷的情況
  • 軟骨、半月軟骨修複用產品的開發
    • 半月軟骨的治療
    • 髖關節用的軟骨產品的開發
  • 早期治癒的生技藥品
  • 設備的標準化與改善
    • 髖關節、肩關節用的器具類
    • 螺絲起子的標準化
  • 專門醫生的訓練計劃
  • 高級材料的研究
  • 生物吸收性技術的開發
  • 集中化
  • 成本控制的必要性
  • 縫合錨釘產品的開發

第6章 市場機會分析

  • 訓練計劃的追加
  • 產品線的擴張
  • 在運動醫學領域缺乏價格壓力
  • 企業合併、收購(M&A)
  • 運動醫學的季節性
  • 新興國家市場
  • 微創手術的偏好

第7章 市場促進、阻礙因素與替代的因素

  • 推動市場要素:相關疾病的得病率上升
    • 運動相關的損傷
    • 老化
    • 外傷
  • 推動市場要素:髖關節的內視鏡檢驗
    • 大腿髖骨臼撞擊的成長
    • 髖關節內視鏡檢驗的專門醫生訓練計劃
  • 推動市場要素:膝關節、肩關節的內視鏡檢驗
  • 推動市場要素:重新置換手術
  • 推動市場要素:患者的要求和認知度
  • 推動市場要素:生物性骨材的發展
    • 骨移植片
    • 多血小板血漿
  • 推動市場要素:小企業的競爭激烈與創新
  • 推動市場要素:材料的開發
    • 複合材料和生物聚合物
    • 生物吸收性材料
    • 整形外科用的金屬合金
  • 市場阻礙因素:對內視鏡檢驗成果的疑問
    • 髖關節的情況
    • 膝關節的情況
  • 市場阻礙因素:陡峭的學習曲線
  • 市場阻礙因素:醫療費給付
  • 市場阻礙因素:強化法規的負擔
  • 市場阻礙因素:功效的改善
  • 市場阻礙因素:醫療設備的物品稅
  • 替代的因素:開放手術 vs. 微創內視鏡手術
  • 替代的因素:保存療法的選擇

第8章 競爭企業的評估

  • 概要
  • 已上市產品(計8公司份)

第9章 開發平台評估

  • 概要
  • 產品簡介(共8產品)

第10章 值得注意的臨床實驗(共13件)

第11章 現在、未來市場參與企業

  • 企業策略的趨勢
  • 企業簡介(共9家份)
    • Arthrex
    • ArthroCare Corporation
    • Biomet
    • ConMed Corporation
    • DePuy Companies
    • Smith & Nephew
    • Stryker
    • Tornier
    • Wright Medical Group
    • 其他的企業

第12章 市場未來展望

  • 各企業的市場佔有率
    • 全球
    • 美國
  • 美國市場預測

第13章 附錄

圖表一覽

目錄
Product Code: GDME1093CFR

This report focuses on the sports medicine market, which includes implants and arthroscopic capital equipment. The orthopedic sports medicine market has been estimated in this report and covers the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India. The report provides unmet needs, future adoption and compound annual growth rates (CAGR). GlobalData's analysis shows that while the orthopedics implant market is mature, sports medicine is an area with the potential for significant international growth. With the market, the US remains to be the largest market with the EU to follow and growing. The APAC region while markedly smaller has a large potential patient population.The top six to seven market leaders continue to dominate the market through technological innovation and investment in establishing strong distribution networks. The major opportunity lies within technological advancement and the clinical trials to prove effectiveness of new techniques.

The US sports medicine market is a strong and growing market, with prevalence of sports-related injury rising most rapidly among the young and old. The biggest player in sports medicine in the US remains Arthrex, leading with a 21% market share. This company has the strongest brand identity and offers a wide selection of products, which makes it competitive and able to maintain its market share.

Scope

  • An overview of sports medicine, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
  • Annualized the US sports medicine market revenue and future forecasts from 2009 to 2011, forecast for 7 years to 2018.
  • Investigation of current and future market competition for sports medicine.
  • Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
  • Competitor assessment including device approval analysis and device sales forecasts.
  • Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
  • Analysis of unmet needs within the market and opportunities for future players.
  • Technology trends evaluation to assess strength of pipeline.
  • An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
  • Company profiles including business description, financial overview and SWOT analysis.
  • Coverage of key market players.
  • Strategic assessment of the sports medicine sector through market impact analysis, future market scenario and company analysis.
  • Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists

Reasons to buy

  • Understand the trends shaping and driving the US sports medicine market.
  • Realize device preferences of physicians who have performed the tests already.
  • Access market sizing, forecasts and quantified growth opportunities in the US sports medicine market through 2018.
  • Quantify candidate patient populations to better design product pricing & launch plans.
  • Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
  • Perform benchmarking analysis of growth opportunities against currently marketed products.
  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
  • Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
  • What's the next big thing in the US sports medicine market landscape? Identify, understand and capitalize.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports
  • 2.3. Upcoming Related Reports

3. Clinical Outcomes

  • 3.1. Conservative Treatments
    • 3.1.1. Immobilization and Bracing
    • 3.1.2. Physical Therapy
    • 3.1.3. Muscle Stimulation
  • 3.2. Drug Therapy
    • 3.2.1. Nutritional Supplements
    • 3.2.2. Analgesics and NSAIDs
    • 3.2.3. Corticosteroids
    • 3.2.4. Viscosupplementation
  • 3.3. Soft Tissue Repair
  • 3.4. Arthroscopy
  • 3.5. Plates and Screws
  • 3.6. Joint Replacement

4. Industry Overview

  • 4.1. Overview
  • 4.2. Procedure Trends
    • 4.2.1. US
  • 4.3. Market Access
    • 4.3.1. US
  • 4.4. Disputes and Settlements
    • 4.4.1. Smith & Nephew Granted an Injunction Against Arthrex
    • 4.4.2. KFx Medical and Smith & Nephew Enter Into Licensing Agreement
    • 4.4.3. KFx Medical Wins Patent Infringement Lawsuit Against Arthrex
    • 4.4.4. ArthroCare and Smith & Nephew Settle Legal Disputes
  • 4.5. Mergers, Acquisitions, Partnerships, and Other Deals
    • 4.5.1. Stryker Acquires Pivot Medical
    • 4.5.2. Smith & Nephew Announces Acquisition of ArthroCare
    • 4.5.3. Smith & Nephew Acquires Plato Grup Assets
    • 4.5.4. Smith & Nephew Announces Acquisition of Its Brazil Distribution Business
    • 4.5.5. Kensey Nash Acquires Minority Stake in Orteq Sports Medicine
    • 4.5.6. Tornier Acquires C2M Medical
    • 4.5.7. Tornier Signs Licensing Agreement with T.A.G. Medical Products Corporation
    • 4.5.8. Biomet Acquires Cartilix
    • 4.5.9. Biomet Sports Medicine Enters Into Deal With Marc Tec
  • 4.6. Economic Impact
    • 4.6.1. Developed Countries
    • 4.6.2. Emerging Markets

5. Unmet Needs

  • 5.1. Long-Term Clinical Data
    • 5.1.1. Hip Arthroscopic Implants Clinical Data
    • 5.1.2. Rotator Cuff Injury Clinical Data
  • 5.2. Cartilage and Meniscal Repair Product Development
    • 5.2.1. Knee Meniscus Treatment
    • 5.2.2. Hip Cartilage Product Development
  • 5.3. Biologics for Faster Healing
  • 5.4. Standardization and Improvement of Instruments
    • 5.4.1. Hip and Shoulder Instrumentation
    • 5.4.2. Screwdriver Standardization
  • 5.5. Fellowship Training Programs
  • 5.6. Advanced Materials Research
  • 5.7. Bioabsorbable Technology Development
  • 5.8. Centralization
  • 5.9. Need for Cost-Containment
  • 5.10. Suture Anchor Product Development

6. Market Opportunity Analysis

  • 6.1. Adding More Training Programs
  • 6.2. Product Line Extensions
  • 6.3. Lack of Pricing Pressure in Sports Medicine
  • 6.4. Mergers and Acquisitions
  • 6.5. Seasonality of Sports Medicine
  • 6.6. Emerging Markets
  • 6.7. Minimally-Invasive Surgical Preference

7. Market Drivers, Barriers and Substitutes

  • 7.1. Driver: Rising Prevalence
    • 7.1.1. Sports-Related Injuries
    • 7.1.2. Aging
    • 7.1.3. Trauma
  • 7.2. Driver: Hip Arthroscopy
    • 7.2.1. Femoroacetabular Impingement Growth
    • 7.2.2. Hip Arthroscopy Fellowship Training Programs
  • 7.3. Driver: Knee and Shoulder Arthroscopy
  • 7.4. Driver: Revision Surgery
  • 7.5. Driver: Patient Demand and Awareness
  • 7.6. Driver: Orthobiologics Development
    • 7.6.1. Bone Grafts
    • 7.6.2. Platelet-Rich Plasma
  • 7.7. Driver: Rising Competition and Innovation Through Small Players
  • 7.8. Driver: Materials Development
    • 7.8.1. Composite Materials and Biopolymers
    • 7.8.2. Bioabsorbables
    • 7.8.3. Metallic Alloys in Orthopedics
  • 7.9. Barrier: Arthroscopy's Questionable Outcomes
    • 7.9.1. Hip Arthroscopy
    • 7.9.2. Knee Arthroscopy
  • 7.10. Barrier: Steep Learning Curve
  • 7.11. Barrier: Reimbursement
  • 7.12. Barrier: Burden of Rising Regulation
  • 7.13. Barrier: Proving Efficacy
  • 7.14. Barrier: Medical Device Excise Tax
  • 7.15. Substitute: Open Surgery Versus Minimally-Invasive Arthroscopy
  • 7.16. Substitute: Conservative Treatment Options

8. Competitive Assessment

  • 8.1. Overview
  • 8.2. Marketed Products in Sports Medicine
    • 8.2.1. Arthrex
    • 8.2.2. ArthroCare Corporation
    • 8.2.3. Biomet
    • 8.2.4. ConMed Corporation
    • 8.2.5. DePuy Mitek
    • 8.2.6. Smith & Nephew
    • 8.2.7. Stryker
    • 8.2.8. Tornier

9. Pipeline Assessment

  • 9.1. Overview
  • 9.2. Product Profiles
    • 9.2.1. Bioretec Drug-Releasing Screws
    • 9.2.2. Nanova Bioabsorbable Bone Screws
    • 9.2.3. MinInvasive Arthroscopic Suture Passer
    • 9.2.4. SpineSmith Pipeline
    • 9.2.5. DePuy Mitek FMS VUE
    • 9.2.6. Pivot Medical Hip Arthroscopy System
    • 9.2.7. University of Florida Shoulder Labral Anchor Delivery System
    • 9.2.8. University of California at San Diego Cartilage Regeneration Device

10. Clinical Trials to Watch

  • 10.1. Overview
  • 10.2. Can Shoulder Arthroscopy Work (CSAW) Study
  • 10.3. Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear
  • 10.4. Knee Arthroscopy Cohort Southern Denmark
  • 10.5. Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement
  • 10.6. Femoroacetabular Impingement Randomized Controlled Trial
  • 10.7. Multicenter ACL Revision Study (MARS)
  • 10.8. Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability
  • 10.9. Microfracture in the Knee Study
  • 10.10. Single- Versus Double-Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears
  • 10.11. Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE)
  • 10.12. Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty
  • 10.13. Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma
  • 10.14. Tibial Tunnel Widening in ACL Reconstruction-Comparing Two Bioscrews

11. Current and Future Players

  • 11.1. Trends in Corporate Strategy
  • 11.2. Company Profiles
    • 11.2.1. Arthrex
    • 11.2.2. ArthroCare Corporation
    • 11.2.3. Biomet
    • 11.2.4. ConMed Corporation
    • 11.2.5. DePuy Companies
    • 11.2.6. Smith & Nephew
    • 11.2.7. Stryker
    • 11.2.8. Tornier
    • 11.2.9. Wright Medical Group
    • 11.2.10. Other Key Players in Sports Medicine

12. Market Outlook

  • 12.1. Company Market Share
    • 12.1.1. Overview
    • 12.1.2. US
  • 12.2. US Market Outlook

13. Appendix

  • 13.1. Bibliography
  • 13.2. Abbreviations
  • 13.3. Research Methodology
    • 13.3.1. Overview
    • 13.3.2. Coverage
    • 13.3.3. Secondary Research
  • 13.4. Physicians and Specialists Included in this Study
    • 13.4.1. Dr. Henry D.E. Atkinson
    • 13.4.2. Dr. Joshua Alpert
    • 13.4.3. Dr. Andrea Ferretti
    • 13.4.4. Dr. Alejandro Gonzalez Della Valle
    • 13.4.5. Dr. Andreas Imhoff
    • 13.4.6. Dr. Marcello Zaia Oliveira
    • 13.4.7. Dr. Vidhya Ravi
    • 13.4.8. Dr. Elvire Servien
    • 13.4.9. Dr. Yotaro Yamakado
  • 13.5. Primary Research
    • 13.5.1. Primary Research - Key Opinion Leader Interviews
    • 13.5.2. Primary Research - Physician and Industry Interviews
    • 13.5.3. Expert Panel Validation
  • 13.6. Forecasting Methodology
  • 13.7. About the Authors
    • 13.7.1. Analysts
    • 13.7.2. Global Head of Healthcare
  • 13.8. About MediPoint
  • 13.9. About GlobalData
  • 13.10. Disclaimer

List of Tables

  • Table 1: Most Common Soft Tissue Injuries to the Extremities in Sports Medicine
  • Table 2: Growth Rates for Arthroscopy by Joint in the US, 2013-2020
  • Table 3: Medicare ICD-9 Diagnosis Codes for Common Sports Medicine Injuries, 2013
  • Table 4: Medicare National Adjusted Reimbursement Rates for Common Sports Medicine Injuries for Hospital Outpatient Treatment, 2013
  • Table 5: Medicare DRG Payments to Hospitals for Common Sports Medicine Injuries, 2013
  • Table 6: Direct, Indirect, and Intangible Costs of Orthopedics
  • Table 7: Potential Market for Meniscus Treatment Types
  • Table 8: Metal Implant CharacteristicsThat Can Be Improved
  • Table 9: Arthrex Shoulder Implants
  • Table 10: Arthrex, Shoulder Instrumentation
  • Table 11: Arthrex, Knee Sutures and Suture Anchors
  • Table 12: Arthrex, Knee Graft Fixation Devices and Meniscal Products
  • Table 13: Arthrex, Hip Implants and Instruments
  • Table 14: Arthrex, Arthroscopy Procedure Capital Equipment
  • Table 15: Arthrex, Implants SWOT Analysis
  • Table 16: Arthrex, Instrumentation SWOT Analysis
  • Table 17: Arthrocare, Suture Implants
  • Table 18: ArthroCare, Suture Management Products
  • Table 19: ArthroCare, Cruciate Ligament Graft Fixation Products
  • Table 20: ArthroCare, Capital Equipment and Instruments
  • Table 21: ArthroCare, Implants SWOT Analysis
  • Table 22: Arthrocare, Instruments and Capital Equipment SWOT Analysis
  • Table 23: Biomet, Shoulder Arthroscopy Products
  • Table 24: Biomet, Knee Arthroscopy Products
  • Table 25: Biomet's Other Joints Arthroscopy Products
  • Table 26: Biomet, Capital Equipment Sports Medicine Products
  • Table 27: Biomet Implants SWOT Analysis
  • Table 28: Biomet, Capital Equipment SWOT Analysis
  • Table 29: ConMed, Shoulder Arthroscopy Products
  • Table 30: ConMed, Knee Arthroscopy Products
  • Table 31: ConMed, Small Joint and Hip Arthroscopy Products
  • Table 32: ConMed, Instruments and Capital Equipment
  • Table 33: ConMed, Implants SWOT Analysis
  • Table 34: ConMed, Capital Equipment SWOT Analysis
  • Table 35: DePuy Mitek, Fixation Devices
  • Table 36: DePuy, Mitek Instruments
  • Table 37: DePuy Mitek, Capital Equipment
  • Table 38: DePuy Mitek Implants, SWOT Analysis
  • Table 39: DePuy Mitek, Capital Equipment SWOT Analysis
  • Table 40: Smith & Nephew, Fixation Devices
  • Table 41: Smith & Nephew, Instruments and Capital Equipment
  • Table 42: Smith & Nephew Implants, SWOT Analysis
  • Table 43: Smith & Nephew, Capital Equipment SWOT Analysis
  • Table 44: Stryker, Fixation Devices
  • Table 45: Stryker, Instrumentation
  • Table 46: Stryker, Capital Equipment
  • Table 47: Stryker, Fixation Devices SWOT Analysis
  • Table 48: Stryker, Instrumentation and Capital Equipment SWOT Analysis
  • Table 49: Tornier Sports Medicine Products
  • Table 50: Tornier, Product Family SWOT Analysis
  • Table 51: Can Shoulder Arthroscopy Work (CSAW)
  • Table 52: Arthroscopy in the Treatment of Degenerative Medial Meniscus Tear
  • Table 53: Knee Arthroscopy Cohort Southern Denmark
  • Table 54: Hip Arthroscopy Versus Conservative Management of Femoroacetabular Impingement
  • Table 55: Femoroacetabular Impingement Randomized Controlled Trial
  • Table 56: Multicenter ACL Revision Study (MARS)
  • Table 57: Arthroscopic Versus Open Stabilization for Traumatic Shoulder Instability
  • Table 58: Results at 10 to 14 Years After Microfracture in the Knee
  • Table 59: Single Versus Double Row Suture Anchor Repair in Medium to Large Rotator Cuff Tears
  • Table 60: Early Surgery Versus Conservative Therapy for Meniscal Injuries in Older Patients (ESCAPE)
  • Table 61: Arthroscopic Rotator Cuff Repair of Full Thickness Tears With and Without Arthroscopic Acromioplasty
  • Table 62: Arthroscopic Rotator Cuff Repair With Platelet-Rich Plasma in Large to Massive Tears
  • Table 63: Tibial Tunnel Widening in Anterior Cruciate Ligament Reconstruction Comparing Two Bioscrews
  • Table 64: Company Profile - Arthrex
  • Table 65: SWOT Analysis - Arthrex
  • Table 66: Company Profile - ArthroCare Corporation
  • Table 67: SWOT Analysis - ArthroCare Corporation
  • Table 68: Company Profile - Biomet
  • Table 69: SWOT Analysis - Biomet
  • Table 70: Company Profile - ConMed Corporation
  • Table 71: SWOT Analysis - ConMed Corporation
  • Table 72: Company Profile - DePuy Companies
  • Table 73: SWOT Analysis - DePuy Companies
  • Table 74: Company Profile - Smith & Nephew
  • Table 75: SWOT Analysis - Smith & Nephew
  • Table 76: Company Profile - Stryker
  • Table 77: SWOT Analysis - Stryker
  • Table 78: Company Profile - Tornier
  • Table 79: SWOT Analysis - Tornier
  • Table 80: Company Profile - Wright Medical Group
  • Table 81: SWOT Analysis - Wright Medical Group
  • Table 82: Other Sports Medicine Companies in the US Market
  • Table 83: Other Sports Medicine Companies in the EU Market
  • Table 84: Other Sports Medicine Companies in the APAC Market
  • Table 85: US Sports Medicine Sales Forecast ($m), 2011-2020
  • Table 86: Primary Research Interviews Completed in Sports Medicine

List of Figures

  • Figure 1: Global Arthroscopic Procedure Volumes by Joint, 2011-2020
  • Figure 2: US Arthroscopic Procedure Volumes, 2011-2020
  • Figure 3: US Arthroscopic Procedure Volumes by Joint, 2011-2020
  • Figure 4: Sources of Orthopedic Trauma (%) (n=103)
  • Figure 5: US Market Share for Arthroscopy, 2012
  • Figure 6: US Sports Medicine Sales Forecast ($m), 2011-2020
Back to Top